Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 8:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2545–2568 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Preeclampsia, Eclampsia, HELLP Syndrome, Toxemia, Hypertensive Disorder of Pregnancy
Interventions: Not listed
Lead sponsor: Preeclampsia Foundation; Other
Eligibility: 13 Years and older
Enrollment: 20,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2040
U.S. locations: 1
States / cities: Melbourne, Florida

Conditions: Glaucoma
Interventions: MicroPulse Transscleral Laser Therapy using revised P3 Delivery Device; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Pulmonary Arterial Hypertension
Interventions: Blood Sampling, Cardiac MRI; Procedure · Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: High Blood Pressure
Interventions: Guided Breathing, RESPeRATE; Behavioral · Device
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 40 Years to 70 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Diabetes Mellitus, Chronic Disease
Interventions: ECHO program for DMMC, Usual care; Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 89 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Santa Fe, New Mexico

Conditions: Hypertension, Stroke
Interventions: Text messaging; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Diabetes, Hypertension, Hyperlipidemia, Heart Diseases, Depression, Psychoses
Interventions: pharmacist contact with the patient via telephone, Pharmacist contact with the patient's physician via fax, Usual care; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: Not listed
Enrollment: 3,048 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Hypertension
Interventions: SERVE OC Intervention, Enhanced Standard Intervention; Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 5 Years and older
Enrollment: 483 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Irvine, California

Conditions: Glaucoma
Interventions: Brimonidine Purite 0.15%, Dorzolamide 2%, Latanoprost; Drug
Lead sponsor: Innovative Medical; Industry
Eligibility: 18 Years and older
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Hypertension, Blood Pressure
Interventions: Group Visits; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 21 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Congenital Diaphragmatic Hernia, Pulmonary Hypoplasia, Pulmonary Hypertension
Interventions: FETO, Fetal Endoluminal Tracheal Occlusion; Device
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2033
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Essential Hypertension
Interventions: Aliskiren, Placebo to Aliskiren; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 328 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Zanesville, Ohio

Conditions: Hypertension
Interventions: Precision Spectra System, Exercise Intervention; Device · Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 40 Years to 90 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Minneapolis, Minnesota

Conditions: Hypertension
Interventions: Sleep Extension, Sleep Timing; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 25 Years to 70 Years
Enrollment: 270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cataract, Macular Degeneration, Glaucoma
Interventions: Technology-based Eye Care Services (TECS) Protocol; Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Hypertension
Interventions: mGlide; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 85 Years
Enrollment: 395 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Desaturation, Bradycardia, Tachycardia, Hypertension, Hypotension
Interventions: Rapid Response Team (NTX wireless monitoring system); Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,303 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Pulmonary Hypertension
Interventions: Sildenafil citrate; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 24
States / cities: Birmingham, Alabama • La Jolla, California • Los Angeles, California + 13 more

Conditions: Hypertension, Self-management, Technology
Interventions: Technology-based Component, TechSupport; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 25 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Preeclampsia With Severe Features
Interventions: Experimental labetalol dose, Current standard of care; Drug · Other
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Albany, New York

Conditions: Post Term Pregnancy, Premature Rupture of Membrane, Fetal Growth Retardation, Oligohydramnios, Gestational Diabetes, High Blood Pressure in Pregnancy
Interventions: Dilapan-S; Device
Lead sponsor: Medicem Technology s.r.o.; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Primary Open Angle Glaucoma
Interventions: GlaucoCetin, Placebo; Dietary Supplement · Other
Lead sponsor: Wills Eye; Other
Eligibility: 40 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Preeclampsia
Interventions: Aspirin 162 mg; Drug
Lead sponsor: Methodist Medical Center of Illinois; Other
Eligibility: Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Peoria, Illinois

Conditions: Glaucoma, Ocular Hypertension
Interventions: Not listed
Lead sponsor: Robin, Alan L., M.D.; Individual
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

The Preeclampsia Registry

Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients

Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH

Breathe: Slow Paced Breathing to Lower Blood Pressure

ECHO for Diabetes and Multiple Chronic Conditions Study

REACH OUT: to Reduce High Blood Pressure in the Emergency Department

Pharmacy Interventions to Improve Chronic Disease Medication Refill

Skills-Based Educational Strategies for Reduction of Vascular Events in Orange County

Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost

Veteran Preference For Group Visits and Its Effect on Hypertension Outcomes

Safety and Efficacy of FETO in CDH Phase III

Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension.

Spinal Cord Stimulation to Treat Hypertension

Mechanisms Underlying the Blood Pressure Lowering Effect of Sleep

Technology-based Eye Care Services (TECS) Compare

mGlide RCT: A Clinical Glide Path To Close the Guideline-to-Practice Gap In HTN Management

Validation of the NTX Wireless Patient Monitoring System

Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension

Technology-based Intervention and Positive Psychological Training for Blood Pressure Control in African Americans

Acute Labetalol Use in Preeclampsia

Dilapan-S®: A Multicenter US E-registry

Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin

162 mg of Aspirin for Prevention of Preeclampsia

An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation